
Guardant Health, Inc.: updates and filings
Price
$145.14
November 18, 2026Market cap $19.0B
What Ploutos Investor adds for Guardant Health
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Jan 29, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
- 16MonDealMaterial agreement entered, new material financial obligation, unregistered sale of shares, other material eventsDocument
- 5ThuReportQuarterly report · for the period to Sep 30, 2026Document
- 5ThuResultsResults of operationsDocument
- 3TuePeopleOfficer or director changeDocument
- 3TuePeopleOfficer or director changeDocument
July 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Material agreement entered, new material financial obligation, unregistered sale of shares, other material eventsForm8-K
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Nov 5, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 3, 2026Officer or director changeForm8-K
- Nov 3, 2026Officer or director changeForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 30, 2026Shelf registration for future offeringsFormS-3ASR
- Jul 30, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 30, 2026Results of operationsForm8-K
- Jul 28, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jun 18, 2026Shareholder voteForm8-K
- Jun 15, 2026Filing (amendment)Form144/A
- May 15, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 7, 2026Results of operationsForm8-K
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 28, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 28, 2026Additional annual meeting materialFormDEFA14A
- Apr 28, 2026Annual meeting proxy statementFormDEF 14A
- Apr 27, 2026Officer or director changeForm8-K
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 20, 2026Shares registered for employeesFormS-8
- Feb 19, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 19, 2026Results of operationsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | 8-K | Material agreement entered, new material financial obligation, unregistered sale of shares, other material events | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Nov 5, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 3, 2026 | 8-K | Officer or director change | Document |
| Nov 3, 2026 | 8-K | Officer or director change | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 30, 2026 | S-3ASR | Shelf registration for future offerings | Document |
| Jul 30, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 30, 2026 | 8-K | Results of operations | Document |
| Jul 28, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jun 18, 2026 | 8-K | Shareholder vote | Document |
| Jun 15, 2026 | 144/A | Filing (amendment) | Document |
| May 15, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 7, 2026 | 8-K | Results of operations | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 28, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 28, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 28, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 27, 2026 | 8-K | Officer or director change | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 20, 2026 | S-8 | Shares registered for employees | Document |
| Feb 19, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 19, 2026 | 8-K | Results of operations | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 14, 2014.
The full analysis
What do Guardant Health's filings show?
The filings are where every one of Guardant Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.